Taxotere and Hypercalcaemia aggravated - a phase IV clinical study of FDA data

Summary:

Hypercalcaemia aggravated is reported as a side effect among people who take Taxotere (docetaxel), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Zometa, and have Sleep disorder.

The phase IV clinical study analyzes which people have Hypercalcaemia aggravated when taking Taxotere. It is created by eHealthMe based on reports of 62,318 people who have side effects when taking Taxotere from the FDA, and is updated regularly.

What is Taxotere?

Taxotere has active ingredients of docetaxel. It is often used in breast cancer. eHealthMe is studying from 62,513 Taxotere users. Check the latest studies of Taxotere.

What is Hypercalcaemia aggravated?

Hypercalcaemia aggravated (elevated calcium (ca+) level in the blood. (norma) is found to be associated with 932 drugs and 344 conditions by eHealthMe. Check the latest studies of Hypercalcaemia aggravated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 05, 2026

62,318 people reported to have side effects when taking Taxotere.
Among them, 86 people (0.14%) have Hypercalcaemia aggravated.

Could Taxotere cause Hypercalcaemia aggravated?

Among these 86 people:

How long have people been on Taxotere when they have Hypercalcaemia aggravated? *

What is the gender of people who have Hypercalcaemia aggravated when taking Taxotere? *

female: 58.73 %
male: 41.27 %

What is the age of people who have Hypercalcaemia aggravated when taking Taxotere? *

What are other drugs people take besides Taxotere? *

What are other side effects people have besides Hypercalcaemia aggravated? *

Fatigue (feeling of tiredness): 48 people, 55.81%
Dyspnea (difficult or laboured breathing): 44 people, 51.16%
Weakness: 42 people, 48.84%
Nausea (feeling of having an urge to vomit): 39 people, 45.35%
Pain: 39 people, 45.35%
Cough: 36 people, 41.86%
Pleural Effusion (water on the lungs): 35 people, 40.70%
Dehydration (dryness resulting from the removal of water): 33 people, 38.37%
Pain In Extremity: 33 people, 38.37%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 32 people, 37.21%

What are the existing conditions these people have? *

Muscle Spasms (muscle contraction): 26 people, 30.23%
Nausea (feeling of having an urge to vomit): 26 people, 30.23%
Depression: 26 people, 30.23%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 26 people, 30.23%
Sleep Disorder: 26 people, 30.23%
Metastases To Bone (cancer spreads to bone): 13 people, 15.12%
Lung Cancer - Non-Small Cell (lung cancer): 4 people, 4.65%
Breast Cancer Female: 2 people, 2.33%
Rashes (redness): 2 people, 2.33%
Osteonecrosis Of Jaw (death of bone of jaw): 2 people, 2.33%

* Approximation only. Some reports may have incomplete information.

Do you take Taxotere and have Hypercalcaemia aggravated?

- Check whether Hypercalcaemia aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Taxotere:

Taxotere (62,513 reports)

Browse all side effects of Taxotere:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypercalcaemia aggravated:

Hypercalcaemia aggravated (932 drugs)

Browse all the conditions that are associated with Hypercalcaemia aggravated:

Hypercalcaemia aggravated (344 conditions)

Related publications that referenced our studies

Byun JS, Kang SH, Lee MJ, Kim SY, Choi HG, Lee HR, "A Case of Scleroderma-like Cutaneous Lesions Induced by Docetaxel in a Patient with Breast Cancer", Journal of Rheumatic Diseases, 2013 Oct .
Byun JS, Kang SH, Lee MJ, Kim SY, Choi HG, Lee HR, "A Case of Scleroderma-like Cutaneous Lesions Induced by Docetaxel in a Patient with Breast Cancer", Journal of Rheumatic Diseases, 2013 Oct .

How the study uses the data?

The study uses data from the FDA. It is based on docetaxel (the active ingredients of Taxotere) and Taxotere (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.